Chemical Compound

Cabozantinib; N'-?[4-?[(6,?7-?Dimethoxy-?4-?quinolinyl)?oxy]?phenyl]?-?N-?(4-?fluorophenyl)?-1,?1-cyclopropanedicarbox?amide; N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; BMS 907351; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide

Name: Cabozantinib; N'-?[4-?[(6,?7-?Dimethoxy-?4-?quinolinyl)?oxy]?phenyl]?-?N-?(4-?fluorophenyl)?-1,?1-cyclopropanedicarbox?amide; N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; BMS 907351; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
Brand: EASY CDMO
SKU: 25102847

CAS Registry Number 849217-68-1

返回搜索申请报价

Primary record

Cabozantinib; N'-?[4-?[(6,?7-?Dimethoxy-?4-?quinolinyl)?oxy]?phenyl]?-?N-?(4-?fluorophenyl)?-1,?1-cyclopropanedicarbox?amide; N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; BMS 907351; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide

库存: 2,716 克
纯度: 99.6 %
CAS: 849217-68-1

化合物标识与属性

CAS: 849217-68-1
PubChem CID: 25102847
SMILES: COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F
Canonical SMILES: COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC

名称与同义词

Cabozantinib
849217-68-1
Cometriq
Cabometyx
cabozantinibum
Carbozantinib
XL-184 free base
XL184
Cabozantinib-d6
XL-184
Cabozantinib malate
Cabometyx (TN)
Cabozantinib [USAN]
Cometriq (TN)
XL 184
XL184 free base
Cabozantinib S-malate
Cabozantinib/XL184
Cabozantinib (USAN)
XL184 cpd
BMS-907351
Cabozantinib XL-184
Cabozantinib, XL184
Cabozantinib (Standard)
Cabozantinib [USAN:INN]
RefChem:57604
BMS 907351
cabozantinib (S)-malate
Cabozantinib (free base)
CABOZANTINIB [MI]
Cabozantinib (XL-184)
Cabozantinib (XL184, BMS-907351)
CABOZANTINIB [INN]
MFCD20926324
cc-10
CHEBI:72317
D0IQ6P
UNII-1C39JW444G
1C39JW444G
A1JS8
CABOZANTINIB [VANDF]
BMS-907351 FREE BASE
C28H24FN3O5
CABOZANTINIB [WHO-DD]
SCHEMBL360795
DTXSID10233968
BMS907351
ONIQOQHATWINJY-UHFFFAOYSA-N
GTPL5887
orb1305297
Cabozantinib (BMS-907351)
CHEMBL2105717
SCHEMBL29351408
DTXCID40156459
EX-A075
L01XE26
QCR-122
SYN1138
XL184 free base - Cabozantinib
BCPP000308
GLXC-90066
HMS3654G06
HMS5079K09
XL-184 free base (Cabozantinib)
AOB87755
BCP02591
849217-68-1 (free base)
ABP000796
BDBM50021574
EBC-17137
HY-13016R
NP3655
NSC761068
NSC800066
s1119
ZINC70466416
AKOS025142112
ACN-031542
BCP9000470
CCG-264678
CS-0278
DB08875
FD59688
NSC-761068
NSC-800066
RL05229
SB20062
SDCCGSBI-0646928.P001
XL-184 (Cabozantinib,BMS907351)
XL-184,Cabozantinib, BMS-907351
N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
NCGC00263164-01
NCGC00263164-14
NCGC00263164-17
AC-25082
AS-16277
BC267213
BP-43629
HY-13016
SC-85393
SY097158
XL-184 (Cabozantinib,BMS907351)?
AB0033751
DB-023624
N'-[4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N-(4-FLUOROPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE
A2977
FT-0664184
NS00020240
SW218093-3
X7477
J3.085.595G
A10996
D10062
Q-3907
AB01565831_02
A841013
Q795057
SR-01000941569
SR-01000941569-1
BRD-K51544265-001-01-8
BRD-K51544265-001-04-2
BRD-K51544265-001-06-7
1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-f
1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
XL 184, XL-184, 1021950-26-4
1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
n-(4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- dicarboxamide
N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
1,1-CYCLOPROPANEDICARBOXAMIDE, N'-(4-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)PHENYL)-N-(4-FLUOROPHENYL)-
1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)-
1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
1802168-46-2
4-[4-[[[1-[(4-Fluorophenyl)aminocarbonyl]cyclopropyl]carbonyl]amino]phenoxy]-6,7-dimethoxyquinoline
Cabozantinib; N'-?[4-?[(6,?7-?Dimethoxy-?4-?quinolinyl)?oxy]?phenyl]?-?N-?(4-?fluorophenyl)?-1,?1-cyclopropanedicarbox?amide; N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; BMS 907351; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide
cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide
cyclopropane-1,1-dicarboxylic acid[4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide
N'1-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4 fluorophenyl)cyclopropane-1,1-dicarboxamide
N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
N-[4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
N~1~-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl}-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide